NKGN
NKGen Biotech Inc

1,293
Loading...
Loading...
News
all
press releases
Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024
Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.
Stocktwits·9mo ago
News Placeholder
More News
News Placeholder
NKGen Biotech to Showcase at Global Investment Conference
NKGen Biotech ( ($NKGN) ) has shared an update. NKGen Biotech, Inc. is set to join the H.C. Wainwright 26th Annual Global Investment Conference on...
TipRanks Financial Blog·1y ago
News Placeholder
Why NKGen Biotech (NKGN) Stock Is Skyrocketing
NKGen Biotech shares are trading higher by 32.5% Thursday morning. The company announced it will present new SNK01 biomarker data at the Alzheimer's Association International Conference. read more...
Benzinga·1y ago
News Placeholder
Why NKGen Biotech Stock Is Moving Higher Monday
NKGen Biotech shares are trading higher Monday after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease. read more...
Benzinga·1y ago
News Placeholder
What's Going On With Nano-Cap NKGen Biotech Stock On Monday?
Latest on NKGen Biotech Inc (NASDAQ: NKGN) as shares surge 25.2% on high volume. Insights into NK cell therapy for neurodegenerative diseases. Developments in Parkinson's and Alzheimer's...
Benzinga·1y ago
News Placeholder
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference
SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid ( CSF ) and plasma Tau proteins in Alzheimer's patients. The additional Phase 1 SNK01 trial data suggest...
Globe Newswire·1y ago
News Placeholder
12 acciones de salud en movimiento en la sesi n intrad a del 06/03/2024
Acciones al alza Aptorum Gr (NASDAQ:APM) experimentaron un repunte del 680,24% para establecerse en los 11,31 d lares durante la sesi n del regular del mi rcoles. NKGen Biotech (NASDAQ:NKGN...
Benzinga·2y ago
News Placeholder
NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer's Disease at the Tau2024 Global Conference
SANTA ANA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) ( NKGen or the Company ), a clinical-stage biotechnology company focused on the development and...
Globe Newswire·2y ago
News Placeholder
NKGen Biotech Enhances Strategic Partnership with Meteora Capital
NKGen Biotech (NKGN) has released an update. NKGen Biotech, Inc., once known as Graf Acquisition Corp. IV, has revised its deal with Meteora Capita...
TipRanks Financial Blog·2y ago
News Placeholder
NKGen Biotech Amends Key Agreement, Increases Prepayment Shortfall
NKGen Biotech (NKGN) has released an update to notify the public and investors about an entry into a material definitive agreement. NKGen Biotech...
TipRanks Financial Blog·2y ago

Latest NKGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.